The Australian Competition Authority clears animal health business merger subject to divestments (Elanco Animal Health / Bayer Animal Health)

Elanco’s acquisition of Bayer’s animal health business not opposed* The ACCC will not oppose Elanco’s acquisition of Bayer AG’s animal health business, after Elanco provided a court-enforceable undertaking to divest four animal parasite treatment brands. The ACCC had concerns about the effect of the acquisition in

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Australian Competition Authority, The Australian Competition Authority clears animal health business merger subject to divestments (Elanco Animal Health / Bayer Animal Health), 9 July 2020, e-Competitions July 2020, Art. N° 95780

Visites 123

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues